1. Home
  2. CLM vs AVDL Comparison

CLM vs AVDL Comparison

Compare CLM & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cornerstone Strategic Value Fund Inc. New

CLM

Cornerstone Strategic Value Fund Inc. New

HOLD

Current Price

$8.20

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.59

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLM
AVDL
Founded
1987
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CLM
AVDL
Price
$8.20
$21.59
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$19.14
AVG Volume (30 Days)
1.4M
1.5M
Earning Date
01-01-0001
03-02-2026
Dividend Yield
18.74%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$248,517,000.00
Revenue This Year
N/A
$65.47
Revenue Next Year
N/A
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.88
52 Week Low
$6.25
$6.38
52 Week High
$8.84
$23.57

Technical Indicators

Market Signals
Indicator
CLM
AVDL
Relative Strength Index (RSI) 36.93 59.76
Support Level $8.20 $21.52
Resistance Level $8.37 $21.65
Average True Range (ATR) 0.09 0.06
MACD -0.02 -0.01
Stochastic Oscillator 21.70 50.00

Price Performance

Historical Comparison
CLM
AVDL

About CLM Cornerstone Strategic Value Fund Inc. New

Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: